Klaria Competitors and Similar CompaniesClear all

Exelixis's competitors and similar companies include Halozyme Therapeutics and Puma Biotechnology.
Exelixis
Exelixis
Exelixis is an oncology company that develops cancer treatments.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
Puma Biotechnology
Puma Biotechnology
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
Founding Date
Founding Date
1994
Founding Date
1998
Founding Date
2010
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Alameda, US HQ
Locations
San Diego, US HQ
Locations
Los Angeles, US HQ
Employees
Employees
1,14712% decrease
Employees
373157% increase
Employees
27214% decrease
Valuation ($)
Valuation ($)
8.2 b
Valuation ($)
6.4 b
Valuation ($)
136.8 m

Financial

Revenue (est.)
Revenue (est.)
$2.3b (FY, 2025)
Revenue (est.)
$1.4b (FY, 2025)
Revenue (est.)
$228.4m (FY, 2025)
Cost of goods
Cost of goods
$83.7m (FY, 2025)
Cost of goods
$228.8m (FY, 2025)
Cost of goods
$58.2m (FY, 2025)
Gross profit
Gross profit
$2.2b (FY, 2025)
Gross profit
$1.2b (FY, 2025)
Gross profit
$170.2m (FY, 2025)
Net income
Net income
$782.6m (FY, 2025)
Net income
$316.9m (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 171.9m
Total funding raised
$ 172m
For sources of this data, please see the company profile

View Company Profiles

Halozyme Therapeutics
HQ
San Diego, US
Employees
373

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.

View company
Puma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

View company